Investigating how certain compounds affect blood cell development
Roles of DPA derived specialized pre-resolving mediators during vertebrate hematopoiesis
This study is looking at how certain natural compounds can help boost the production of blood cells, using zebrafish embryos to find new ways to treat blood disorders like anemia and blood cancers, which could lead to better treatment options for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi Med Ctr NIH-funded |
| Lab location | 1 site (Jackson, United States) |
| Project ID | NIH-10996096 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of specialized pro-resolving mediators derived from docosapentaenoic acid in the development of blood cells. By using zebrafish embryos as a model, the researchers will screen various compounds to identify those that can enhance the production of hematopoietic stem cells and red blood cells. The study aims to evaluate the therapeutic potential of these compounds for treating blood disorders such as anemia and blood cancers. Patients may benefit from new treatment options that target the underlying mechanisms of these diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from blood disorders, including anemia and blood cancers.
Not a fit: Patients with non-blood-related conditions or those who are not adults may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve blood cell production and treat blood-related diseases more effectively.
How similar studies have performed: While the approach of using specialized mediators in blood cell development is promising, it is relatively novel and has not been extensively tested in human subjects.
Where this research is happening
Jackson, United States
- University of Mississippi Med Ctr — Jackson, United States (Active)
Researchers
- Principal investigator: Nguyen, Kim Uyen — University of Mississippi Med Ctr
- Study coordinator: Nguyen, Kim Uyen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.